Skip to main content
Erschienen in: Diabetologia 1/2007

01.01.2007 | Article

Enhanced mitochondrial metabolism may account for the adaptation to insulin resistance in islets from C57BL/6J mice fed a high-fat diet

verfasst von: M. Fex, M. Dekker Nitert, N. Wierup, F. Sundler, C. Ling, H. Mulder

Erschienen in: Diabetologia | Ausgabe 1/2007

Einloggen, um Zugang zu erhalten

Abstract

Aim/hypothesis

Hyperinsulinaemia maintains euglycaemia in insulin-resistant states. The precise cellular mechanisms by which the beta cells adapt are still unresolved. A peripherally derived cue, such as increased circulating fatty acids, may instruct the beta cell to initiate an adaptive programme to maintain glucose homeostasis. When this fails, type 2 diabetes ensues. Because mitochondria play a key role in beta cell pathophysiology, we tested the hypothesis that mitochondrial metabolism is critical for beta cell adaptation to insulin resistance.

Methods

C57BL/6J mice were given high-fat (HF) diet for 12 weeks. We then analysed islet hormone secretion, metabolism in vivo and in vitro, and beta cell morphology.

Results

HF diet resulted in insulin resistance and glucose intolerance but not frank diabetes. Basal insulin secretion was elevated in isolated islets from HF mice with almost no additional response provoked by high glucose. In contrast, a strong secretory response was seen when islets from HF mice were stimulated with fuels that require mitochondrial metabolism, such as glutamate, glutamine, alpha-ketoisocaproic acid and succinate. Moreover, while glucose oxidation was impaired in islets from HF mice, oxidation of glutamine and palmitate was enhanced. Ultrastructural analysis of islets in HF mice revealed an accumulation of lipid droplets in beta cells and a twofold increase in mitochondrial area.

Conclusions/interpretation

We propose that beta cells exposed to increased lipid flux in insulin resistance respond by increasing mitochondrial volume. This expansion is associated with enhanced mitochondrial metabolism as a means of beta cell compensation.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Reaven GM (1993) Role of insulin resistance in human disease (syndrome X): an expanded definition. Annu Rev Med 44:121–131PubMedCrossRef Reaven GM (1993) Role of insulin resistance in human disease (syndrome X): an expanded definition. Annu Rev Med 44:121–131PubMedCrossRef
2.
Zurück zum Zitat Relimpio F (2003) ‘The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes’, by Kahn SE. Diabetologia 46:1707PubMedCrossRef Relimpio F (2003) ‘The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes’, by Kahn SE. Diabetologia 46:1707PubMedCrossRef
3.
4.
Zurück zum Zitat Prentki M, Corkey BE (1996) Are the beta-cell signaling molecules malonyl-CoA and cystolic long-chain acyl-CoA implicated in multiple tissue defects of obesity and NIDDM? Diabetes 45:273–283PubMed Prentki M, Corkey BE (1996) Are the beta-cell signaling molecules malonyl-CoA and cystolic long-chain acyl-CoA implicated in multiple tissue defects of obesity and NIDDM? Diabetes 45:273–283PubMed
5.
Zurück zum Zitat Ahren B, Simonsson E, Scheurink AJ, Mulder H, Myrsen U, Sundler F (1997) Dissociated insulinotropic sensitivity to glucose and carbachol in high-fat diet-induced insulin resistance in C57BL/6J mice. Metabolism 46:97–106PubMedCrossRef Ahren B, Simonsson E, Scheurink AJ, Mulder H, Myrsen U, Sundler F (1997) Dissociated insulinotropic sensitivity to glucose and carbachol in high-fat diet-induced insulin resistance in C57BL/6J mice. Metabolism 46:97–106PubMedCrossRef
6.
Zurück zum Zitat Ahren B, Scheurink AJ (1998) Marked hyperleptinemia after high-fat diet associated with severe glucose intolerance in mice. Eur J Endocrinol 139:461–467PubMedCrossRef Ahren B, Scheurink AJ (1998) Marked hyperleptinemia after high-fat diet associated with severe glucose intolerance in mice. Eur J Endocrinol 139:461–467PubMedCrossRef
7.
Zurück zum Zitat Wollheim CB (2000) Beta-cell mitochondria in the regulation of insulin secretion: a new culprit in type II diabetes. Diabetologia 43:265–277PubMedCrossRef Wollheim CB (2000) Beta-cell mitochondria in the regulation of insulin secretion: a new culprit in type II diabetes. Diabetologia 43:265–277PubMedCrossRef
8.
Zurück zum Zitat Malaisse WJ, Sener A, Malaisse-Legae F, Hutton JC, Christophe J (1981) The stimulus–secretion coupling of amino acid-induced insulin release. Metabolic interaction of l-glutamine and 2-ketoisocaproate in pancreatic islets. Biochim Biophys Acta 677:39–49PubMed Malaisse WJ, Sener A, Malaisse-Legae F, Hutton JC, Christophe J (1981) The stimulus–secretion coupling of amino acid-induced insulin release. Metabolic interaction of l-glutamine and 2-ketoisocaproate in pancreatic islets. Biochim Biophys Acta 677:39–49PubMed
9.
Zurück zum Zitat Maechler P, Wollheim CB (2001) Mitochondrial function in normal and diabetic beta-cells. Nature 414:807–812PubMedCrossRef Maechler P, Wollheim CB (2001) Mitochondrial function in normal and diabetic beta-cells. Nature 414:807–812PubMedCrossRef
10.
Zurück zum Zitat Maechler P (2002) Mitochondria as the conductor of metabolic signals for insulin exocytosis in pancreatic beta-cells. Cell Mol Life Sci 59:1803–1818PubMedCrossRef Maechler P (2002) Mitochondria as the conductor of metabolic signals for insulin exocytosis in pancreatic beta-cells. Cell Mol Life Sci 59:1803–1818PubMedCrossRef
11.
Zurück zum Zitat Sener A, Malaisse WJ (1980) l-leucine and a nonmetabolized analogue activate pancreatic islet glutamate dehydrogenase. Nature 288:187–189PubMedCrossRef Sener A, Malaisse WJ (1980) l-leucine and a nonmetabolized analogue activate pancreatic islet glutamate dehydrogenase. Nature 288:187–189PubMedCrossRef
12.
Zurück zum Zitat Sener A, Malaisse-Lagae F, Malaisse WJ (1981) Stimulation of pancreatic islet metabolism and insulin release by a nonmetabolizable amino acid. Proc Natl Acad Sci USA 78:5460–5464PubMedCrossRef Sener A, Malaisse-Lagae F, Malaisse WJ (1981) Stimulation of pancreatic islet metabolism and insulin release by a nonmetabolizable amino acid. Proc Natl Acad Sci USA 78:5460–5464PubMedCrossRef
13.
Zurück zum Zitat Anello M, Lupi R, Spampinato D et al (2005) Functional and morphological alterations of mitochondria in pancreatic beta cells from type 2 diabetic patients. Diabetologia 48:282–289PubMedCrossRef Anello M, Lupi R, Spampinato D et al (2005) Functional and morphological alterations of mitochondria in pancreatic beta cells from type 2 diabetic patients. Diabetologia 48:282–289PubMedCrossRef
14.
Zurück zum Zitat Koopman R, Schaart G, Hesselink MK (2001) Optimisation of oil red O staining permits combination with immunofluorescence and automated quantification of lipids. Histochem Cell Biol 116:63–68PubMed Koopman R, Schaart G, Hesselink MK (2001) Optimisation of oil red O staining permits combination with immunofluorescence and automated quantification of lipids. Histochem Cell Biol 116:63–68PubMed
15.
Zurück zum Zitat Mulder H, Gebre-Medhin S, Betsholtz C, Sundler F, Ahren B (2000) Islet amyloid polypeptide (amylin)-deficient mice develop a more severe form of alloxan-induced diabetes. Am J Physiol Endocrinol Metab 278:E684–E691PubMed Mulder H, Gebre-Medhin S, Betsholtz C, Sundler F, Ahren B (2000) Islet amyloid polypeptide (amylin)-deficient mice develop a more severe form of alloxan-induced diabetes. Am J Physiol Endocrinol Metab 278:E684–E691PubMed
16.
Zurück zum Zitat Henquin JC (2000) Triggering and amplifying pathways of regulation of insulin secretion by glucose. Diabetes 49:1751–1760PubMed Henquin JC (2000) Triggering and amplifying pathways of regulation of insulin secretion by glucose. Diabetes 49:1751–1760PubMed
17.
Zurück zum Zitat Wollheim CB, Maechler P (2002) Beta-cell mitochondria and insulin secretion: messenger role of nucleotides and metabolites. Diabetes 51(Suppl 1):S37–S42PubMed Wollheim CB, Maechler P (2002) Beta-cell mitochondria and insulin secretion: messenger role of nucleotides and metabolites. Diabetes 51(Suppl 1):S37–S42PubMed
18.
Zurück zum Zitat Malaisse WJ, Malaisse-Lagae F (1968) Stimulation of insulin secretion by noncarbohydrate metabolites. J Lab Clin Med 72:438–448PubMed Malaisse WJ, Malaisse-Lagae F (1968) Stimulation of insulin secretion by noncarbohydrate metabolites. J Lab Clin Med 72:438–448PubMed
19.
Zurück zum Zitat Gao Z, Young RA, Li G et al (2003) Distinguishing features of leucine and alpha-ketoisocaproate sensing in pancreatic beta-cells. Endocrinology 144:1949–1957PubMedCrossRef Gao Z, Young RA, Li G et al (2003) Distinguishing features of leucine and alpha-ketoisocaproate sensing in pancreatic beta-cells. Endocrinology 144:1949–1957PubMedCrossRef
20.
Zurück zum Zitat Fahien LA, MacDonald MJ (2002) The succinate mechanism of insulin release. Diabetes 51:2669–2676PubMed Fahien LA, MacDonald MJ (2002) The succinate mechanism of insulin release. Diabetes 51:2669–2676PubMed
21.
Zurück zum Zitat Reimer MK, Ahren B (2002) Altered beta-cell distribution of pdx-1 and GLUT-2 after a short-term challenge with a high-fat diet in C57BL/6J mice. Diabetes 51(Suppl 1):S138–S143PubMed Reimer MK, Ahren B (2002) Altered beta-cell distribution of pdx-1 and GLUT-2 after a short-term challenge with a high-fat diet in C57BL/6J mice. Diabetes 51(Suppl 1):S138–S143PubMed
22.
Zurück zum Zitat Milburn JL Jr, Ohneda M, Johnson JH, Unger RH (1993) Beta-cell GLUT-2 loss and non-insulin-dependent diabetes mellitus: current status of the hypothesis. Diabetes Metab Rev 9:231–236PubMedCrossRef Milburn JL Jr, Ohneda M, Johnson JH, Unger RH (1993) Beta-cell GLUT-2 loss and non-insulin-dependent diabetes mellitus: current status of the hypothesis. Diabetes Metab Rev 9:231–236PubMedCrossRef
23.
Zurück zum Zitat Unger RH (1995) Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Genetic and clinical implications. Diabetes 44:863–870PubMed Unger RH (1995) Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Genetic and clinical implications. Diabetes 44:863–870PubMed
24.
Zurück zum Zitat Lee Y, Hirose H, Zhou YT, Esser V, McGarry JD, Unger RH (1997) Increased lipogenic capacity of the islets of obese rats: a role in the pathogenesis of NIDDM. Diabetes 46:408–413PubMed Lee Y, Hirose H, Zhou YT, Esser V, McGarry JD, Unger RH (1997) Increased lipogenic capacity of the islets of obese rats: a role in the pathogenesis of NIDDM. Diabetes 46:408–413PubMed
25.
Zurück zum Zitat Johnson JH, Ogawa A, Chen L et al (1990) Underexpression of beta cell high K m glucose transporters in noninsulin-dependent diabetes. Science 250:546–549PubMedCrossRef Johnson JH, Ogawa A, Chen L et al (1990) Underexpression of beta cell high K m glucose transporters in noninsulin-dependent diabetes. Science 250:546–549PubMedCrossRef
26.
Zurück zum Zitat Capito K, Reinsmark R, Thams P (1999) Mechanism of fat-induced attenuation of glucose-induced insulin secretion from mouse pancreatic islets. Acta Diabetol 36:119–125PubMedCrossRef Capito K, Reinsmark R, Thams P (1999) Mechanism of fat-induced attenuation of glucose-induced insulin secretion from mouse pancreatic islets. Acta Diabetol 36:119–125PubMedCrossRef
27.
Zurück zum Zitat Salehi A, Flodgren E, Nilsson NE et al (2005) Free fatty acid receptor 1 (FFA(1)R/GPR40) and its involvement in fatty-acid-stimulated insulin secretion. Cell Tissue Res 322:207–215PubMedCrossRef Salehi A, Flodgren E, Nilsson NE et al (2005) Free fatty acid receptor 1 (FFA(1)R/GPR40) and its involvement in fatty-acid-stimulated insulin secretion. Cell Tissue Res 322:207–215PubMedCrossRef
28.
Zurück zum Zitat Steneberg P, Rubins N, Bartoov-Shifman R, Walker MD, Edlund H (2005) The FFA receptor GPR40 links hyperinsulinemia, hepatic steatosis, and impaired glucose homeostasis in mouse. Cell Metab 1:245–258PubMedCrossRef Steneberg P, Rubins N, Bartoov-Shifman R, Walker MD, Edlund H (2005) The FFA receptor GPR40 links hyperinsulinemia, hepatic steatosis, and impaired glucose homeostasis in mouse. Cell Metab 1:245–258PubMedCrossRef
29.
Zurück zum Zitat Itoh Y, Kawamata Y, Harada M et al (2003) Free fatty acids regulate insulin secretion from pancreatic beta cells through GPR40. Nature 422:173–176PubMedCrossRef Itoh Y, Kawamata Y, Harada M et al (2003) Free fatty acids regulate insulin secretion from pancreatic beta cells through GPR40. Nature 422:173–176PubMedCrossRef
30.
Zurück zum Zitat Rabaglia ME, Gray-Keller MP, Frey BL, Shortreed MR, Smith LM, Attie AD (2005) Alpha-ketoisocaproate-induced hypersecretion of insulin by islets from diabetes-susceptible mice. Am J Physiol Endocrinol Metab 289:E218–E224PubMedCrossRef Rabaglia ME, Gray-Keller MP, Frey BL, Shortreed MR, Smith LM, Attie AD (2005) Alpha-ketoisocaproate-induced hypersecretion of insulin by islets from diabetes-susceptible mice. Am J Physiol Endocrinol Metab 289:E218–E224PubMedCrossRef
31.
Zurück zum Zitat Toye AA, Lippiat JD, Proks P et al (2005) A genetic and physiological study of impaired glucose homeostasis control in C57BL/6J mice. Diabetologia 48:675–686PubMedCrossRef Toye AA, Lippiat JD, Proks P et al (2005) A genetic and physiological study of impaired glucose homeostasis control in C57BL/6J mice. Diabetologia 48:675–686PubMedCrossRef
32.
Zurück zum Zitat Freeman H, Shimomura K, Horner E, Cox RD, Ashcroft FM (2006) Nicotinamide nucleotide transhydrogenase: a key role in insulin secretion. Cell Metab 3:35–45PubMedCrossRef Freeman H, Shimomura K, Horner E, Cox RD, Ashcroft FM (2006) Nicotinamide nucleotide transhydrogenase: a key role in insulin secretion. Cell Metab 3:35–45PubMedCrossRef
33.
Zurück zum Zitat Kulkarni RN, Holzenberger M, Shih DQ et al (2002) Beta-cell-specific deletion of the Igf1 receptor leads to hyperinsulinemia and glucose intolerance but does not alter beta-cell mass. Nat Genet 31:111–115PubMed Kulkarni RN, Holzenberger M, Shih DQ et al (2002) Beta-cell-specific deletion of the Igf1 receptor leads to hyperinsulinemia and glucose intolerance but does not alter beta-cell mass. Nat Genet 31:111–115PubMed
34.
Zurück zum Zitat Kulkarni RN, Bruning JC, Winnay JN, Postic C, Magnuson MA, Kahn CR (1999) Tissue-specific knockout of the insulin receptor in pancreatic beta cells creates an insulin secretory defect similar to that in type 2 diabetes. Cell 96:329–339PubMedCrossRef Kulkarni RN, Bruning JC, Winnay JN, Postic C, Magnuson MA, Kahn CR (1999) Tissue-specific knockout of the insulin receptor in pancreatic beta cells creates an insulin secretory defect similar to that in type 2 diabetes. Cell 96:329–339PubMedCrossRef
Metadaten
Titel
Enhanced mitochondrial metabolism may account for the adaptation to insulin resistance in islets from C57BL/6J mice fed a high-fat diet
verfasst von
M. Fex
M. Dekker Nitert
N. Wierup
F. Sundler
C. Ling
H. Mulder
Publikationsdatum
01.01.2007
Verlag
Springer-Verlag
Erschienen in
Diabetologia / Ausgabe 1/2007
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-006-0464-4

Weitere Artikel der Ausgabe 1/2007

Diabetologia 1/2007 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Strenge Blutdruckeinstellung lohnt auch im Alter noch

30.04.2024 Arterielle Hypertonie Nachrichten

Ältere Frauen, die von chronischen Erkrankungen weitgehend verschont sind, haben offenbar die besten Chancen, ihren 90. Geburtstag zu erleben, wenn ihr systolischer Blutdruck < 130 mmHg liegt. Das scheint selbst für 80-Jährige noch zu gelten.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.